We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$91.3B
AUM Growth
+$2.98B
(+3.4%)
Cap. Flow
-$825M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
34.96%
Holding
259
New
7
Increased
73
Reduced
140
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Airlines
UAL
|
+$144M |
| 2 |
Jacobs Solutions
J
|
+$83.6M |
| 3 |
CSX Corp
CSX
|
+$52.1M |
| 4 |
Ross Stores
ROST
|
+$51.1M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$47.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$218M |
| 2 |
Electronic Arts
EA
|
+$134M |
| 3 |
FedEx
FDX
|
+$124M |
| 4 |
Medtronic
MDT
|
+$120M |
| 5 |
Visa
V
|
+$83.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.32% |
| 2 | Healthcare | 25.97% |
| 3 | Industrials | 13.87% |
| 4 | Financials | 5.85% |
| 5 | Consumer Discretionary | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
NOV
NOV
$7.13B
| $146M | 0.16% |
1,776,586
+344,772
| +24% | +$25.7M |
|
|
ABMD
102
DELISTED
Abiomed Inc
ABMD
| $144M | 0.16% |
5,726,490
-25,500
| -0.4% | -$594K |
|
|
IMGN
103
DELISTED
Immunogen Inc
IMGN
| $141M | 0.15% |
11,922,396
-753,031
| -6% | -$9.45M |
|
|
ATVI
104
DELISTED
Activision Blizzard
ATVI
| $141M | 0.15% |
6,333,100
-18,104
| -0.3% | -$372K |
|
|
CAM
105
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $141M | 0.15% |
2,076,800
-65,988
| -3% | -$4.25M |
|
106
RTX Corp
RTX
$294B
| $139M | 0.15% |
1,913,315
| – | – |
|
|
SFLY
107
DELISTED
Shutterfly, Inc.
SFLY
| $135M | 0.15% |
3,130,718
+414,186
| +15% | +$17M |
|
108
Pentair
PNR
$10.9B
| $133M | 0.15% |
2,748,517
+22,307
| +0.8% | +$1.14M |
|
109
Stratasys
SSYS
$764M
| $133M | 0.15% |
1,166,890
-81,500
| -7% | -$7.99M |
|
110
Norfolk Southern
NSC
$76.7B
| $129M | 0.14% |
1,255,278
-31,000
| -2% | -$3.04M |
|
111
Aecom
ACM
$9.74B
| $128M | 0.14% |
3,989,500
+119,510
| +3% | +$3.86M |
|
112
Rambus
RMBS
$10.9B
| $121M | 0.13% |
8,450,122
-135,461
| -2% | -$1.67M |
|
113
IDEX
IEX
$17.5B
| $120M | 0.13% |
1,490,120
-7,240
| -0.5% | -$548K |
|
114
Curtiss-Wright
CW
$28B
| $117M | 0.13% |
1,787,774
+289,700
| +19% | +$19M |
|
|
TUES
115
DELISTED
Tuesday Morning Corp
TUES
| $116M | 0.13% |
6,483,050
+300
| +0% | +$4.68K |
|
116
Waters Corp
WAT
$38.9B
| $108M | 0.12% |
1,035,761
-4,800
| -0.5% | -$505K |
|
|
CPHD
117
DELISTED
Cepheid Inc
CPHD
| $108M | 0.12% |
2,255,200
-15,200
| -0.7% | -$689K |
|
|
SZYM
118
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $107M | 0.12% |
9,118,409
+937,220
| +11% | +$9.99M |
|
119
Standard BioTools
LAB
$321M
| $107M | 0.12% |
3,651,332
+166,511
| +5% | +$5.34M |
|
|
DYAX
120
DELISTED
DYAX CORPORATION
DYAX
| $107M | 0.12% |
11,129,830
-677,160
| -6% | -$5.16M |
|
|
CIR
121
DELISTED
CIRCOR International, Inc
CIR
| $106M | 0.12% |
1,376,800
+35,115
| +3% | +$2.71M |
|
|
SWN
122
DELISTED
Southwestern Energy Company
SWN
| $104M | 0.11% |
2,292,772
+32,000
| +1% | +$1.48M |
|
123
Revvity
RVTY
$12.4B
| $99.1M | 0.11% |
2,116,374
+300
| +0% | +$13.5K |
|
124
Kirby Corp
KEX
$7.08B
| $99M | 0.11% |
845,089
-66,000
| -7% | -$7.08M |
|
|
NSR
125
DELISTED
Neustar Inc
NSR
| $97.4M | 0.11% |
3,744,401
-36,096
| -1% | -$981K |
|
Similar funds
VAM
Primecap Management's Q2 2014 Portfolio in Review
As of Q2 2014, Primecap Management held 259 positions worth $91.3B, up 3.4% from $88.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q2 2014: portfolio turnover was 4.6%. Primecap Management opened 7 new positions and exited 5, leaving the 259-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q2 2014 buy was Exact Sciences: 2,491,300 shares worth $42.4M.
- Primecap Management added most to United Airlines in Q2 2014, an estimated $144M increase.
- Primecap Management's biggest Q2 2014 reduction was GSK, cutting an estimated $218M.
- Primecap Management fully exited Akamai in Q2 2014, selling an estimated $4.77M.
- Primecap Management's ten largest holdings make up 35% of its $91.3B portfolio in Q2 2014.
- Primecap Management opened 7 new positions and closed 5 in Q2 2014.
- Primecap Management's portfolio value rose 3.4% quarter-over-quarter to $91.3B.
Based on Primecap Management's 13F filing for Q2 2014, filed 14 Aug 2014.